CLINICAL_TRIALS
trial_result
· 2025-03-28
Clinical Trial Update: A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) [Phase 4]
Summary
Phase 4 trial update for apalutamide in Chinese participants with non-metastatic castration-resistant prostate cancer; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 4 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-03-28